Tell us what you think about the new Article Page. Send us feedback
WHEATON, Ill.--(BUSINESS WIRE)--First Trust Specialty Finance and Financial Opportunities Fund (the "Fund") (NYSE: FGB - News) today declared the Fund’s regularly scheduled quarterly distribution of $0.14 per share, payable on December 1, 2009 to shareholders of record on November 20, 2009. The ex-dividend date is expected to be November 18, 2009.
|
First Trust Specialty Finance and Financial Opportunities Fund (FGB): |
|||
| Distribution per share: | $0.14 | ||
| Distribution Rate (annualized) based on the November 9, 2009 NAV of $5.97: | 9.38 | % | |
| Distribution Rate (annualized) based on the November 9, 2009 closing market price of $5.44: | 10.29 | % | |
A portion of the distribution may be treated as paid from sources other than net investment income, including short-term capital gain, long-term capital gain and return of capital. The final determination of the source and tax status of all distributions paid in 2009 will be made after the end of 2009.
The Fund is a non-diversified, closed-end management investment company that seeks to provide a high level of current income. As a secondary objective, the Fund seeks to provide attractive total return. The Fund pursues these investment objectives by investing at least 80% of its managed assets in a portfolio of securities of specialty finance and other financial companies that the Fund’s investment sub-advisor believes offer attractive opportunities for income and capital appreciation.
First Trust Advisors L.P., the Fund’s investment advisor, along with its affiliate First Trust Portfolios L.P., are privately-held companies which provide a variety of investment services, including asset management, financial advisory services, and municipal and corporate investment banking, with collective assets under management or supervision of approximately $22 billion as of October 31, 2009 through closed-end funds, unit investment trusts, mutual funds, separate managed accounts and exchange-traded funds.
Confluence Investment Management LLC (“Confluence”), an SEC registered investment advisor, serves as the Fund’s investment sub-advisor. The investment professionals at Confluence have over 50 years of aggregate portfolio management experience. Confluence provides portfolio management and advisory services to both institutional and individual clients. As of October 31, 2009 Confluence managed or supervised over $600 million in assets.
Past performance is no assurance of future results. Investment return and market value of an investment in the Fund will fluctuate. Shares, when sold, may be worth more or less than their original cost.
Principal Risk Factors: Investment in this Fund involves management risk; sub-advisor risk; value investing risk; income risk; specialty finance and other financial companies risks; common stock risk; preferred stock and trust preferred securities risk; convertible securities risk; fixed-income securities risk; lower grade and distressed securities risk; business development company risk; REIT, mortgage-related and asset-backed securities risks; infrastructure trust risk; income trust and master limited partnership risks; tax risks; non-U.S. securities risk; currency risk; liquidity risk; leverage risk; non-diversification risk; inflation/deflation risk; market discount from net asset value risk; and market disruption risk. The risks of investing in the Fund are spelled out in the prospectus, shareholder report and other regulatory filings.
The Fund’s daily closing New York Stock Exchange price and net asset value per share as well as other information can be found at www.ftportfolios.com or by calling 1-800-988-5891.
First Trust Specialty Finance and Financial Opportunities Fund
Press Inquiries:
Jane Doyle, 630-765-8775
or
Analyst Inquiries:
Jeff Margolin, 630-915-6784
or
Broker Inquiries:
Jeff Margolin, 630-915-6784
Copyright © 2010 Business Wire. All rights reserved. All the news releases provided by Business Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials by posting, archiving in a public web site or database, or redistribution in a computer network is strictly forbidden.